Showing results by author "Mark Leeds D.O." in All Categories

There is a harm reduction protocol to help people reduce alcohol consumption. It is a medication assisted treatment plan known as The Sinclair Method, or TSM. Based on the theories of Nobel Prize winning scientist, Ivan Pavlov, TSM utilizes an effect known as pharmacological extinction. The basics of the method involve taking a naltrexone tablet one hour before having a drink. Of course, there is much to discuss. This is a fascinating alternative way of quitting alcohol gradually which has a 78% success rate.

This podcast is about akathisia stories and akathisia science. Akathisia is a severe movement disorder characterized by restlessness and an inability to sit still. People who suffer with akathisia describe it as severely painful, and like being plugged into an electrical outlet. They often feel as if they want to claw their skin away and climb out of it. This terrible condition is caused by the toxic effects of psych drugs, including benzodiazepines. It is an iatrogenic injury, which means it is caused by medical treatment. People who experience protracted withdrawal from quitting ...

This is the Dr. Leeds podcast, reflecting the content and spirit of the DrLeeds.com website and topics of interest to Dr. Leeds.

This podcast is all about benzodiazepine-related issues.

Ketamine therapy is available in the forms of IV (intravenous) infusion, sublingual ketamine troches, IM (intramuscular) injections, and nasal spray (Spravato/esketamine). Ketamine has been called an anesthetic, a psychedelic, and a nootropic drug. Ketamine-assisted therapy is already available for conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), bipolar depression, addiction, suicidality, chronic pain, neuropathic pain, and migraine headaches.

Welcome to "The Psilocybin Podcast," the podcast that delves into the transformative world of psilocybin and psychedelic medicine. In this series, we explore the evolving landscape of psilocybin as it transitions from a controversial, stigmatized substance to a groundbreaking tool in mental health treatment. Our episodes feature thought-provoking conversations with researchers, clinicians, and policy experts who are leading the charge in psilocybin research and its potential FDA approval.

Welcome to the Prescription Digital Therapeutics Podcast – your digital dose of the latest advancements and insights into the burgeoning world of digital health. As technology and healthcare increasingly converge, a new era of treatment possibilities is emerging, where software is not just an adjunct, but a primary tool in treating various health conditions.